Search - tctmd.com

Displaying 1 - 20 of 150

Sort: Relevancy | Date

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News ESC 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

L.A. McKeown

September 05, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

L.A. McKeown

February 13, 2025

News Daily News

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

L.A. McKeown

January 16, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News VIVA 2024

Advocates Urge Heat Maps and Grassroots Campaigns to Improve PAD Care

L.A. McKeown

November 07, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News ESC 2024

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

Caitlin E. Cox

September 10, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Platelet Hyperreactivity Score May Improve CVD Risk Detection

L.A. McKeown

August 23, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

L.A. McKeown

July 24, 2024

Advertisement

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

AHA Scientific Statement Takes Aim at PAD Pain

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

Top Endovascular News of 2024

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

Advocates Urge Heat Maps and Grassroots Campaigns to Improve PAD Care

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

September 2024 Dispatch for the CV Team

Scientific Statement Reviews Current Antithrombotic Options in PAD

Platelet Hyperreactivity Score May Improve CVD Risk Detection

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content